Hirak Shah, MD
Advanced Heart Failure and Transplant Cardiology · Kansas City, KSNPI 1760897417
Payments from drug & device makers
Across 377 payments — averaging $4529.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endotronix, Inc.$1M
- Edwards Lifesciences$377K
- Impulse Dynamics (USA) Inc.$140K
- Abbott$52K
- Livanova USA, Inc.$40K
- Cvrx, Inc.$26K
- plus $24K from 21 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endotronix, Inc. | 11 | $1,048,097 |
| Edwards Lifesciences | 32 | $376,750 |
| Impulse Dynamics (USA) Inc. | 88 | $140,270 |
| Abbott | 90 | $51,954 |
| Livanova USA, Inc. | 7 | $40,323 |
| Cvrx, Inc. | 4 | $26,225 |
| Paragonix Technologies, Inc. | 8 | $20,444 |
| Abiomed | 7 | $863 |
| E.r. Squibb & Sons, L.L.C. | 53 | $759 |
| AstraZeneca | 15 | $459 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 14 | $377 |
| Merck | 16 | $299 |
| Medtronic | 2 | $146 |
| Pfizer | 5 | $88 |
| Novo Nordisk | 3 | $79 |
| Ancora Heart, Inc. | 3 | $72 |
| Irhythm Technologies, Inc. | 3 | $61 |
| Alnylam Pharmaceuticals Inc. | 3 | $58 |
| Boehringer Ingelheim | 3 | $52 |
| Daiichi Sankyo Inc. | 2 | $46 |
| Procyrion, Inc. | 1 | $40 |
| Scpharmaceuticals Inc. | 2 | $38 |
| Sanofi | 1 | $26 |
| Lexicon Pharmaceuticals, Inc. | 1 | $24 |
| Novartis | 1 | $16 |
| Boston Scientific | 1 | $15 |
| Getinge USA Sales, LLC | 1 | $12 |
How this compares
Too few advanced heart failure and transplant cardiology providers in Kansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in Kansas City
- Zubair ShahKansas City$2.3M
- Paola RoldanKansas City$77K
- Pradeep MammenKansas City$18K
- Tarun DaliaKansas City$16K
- Michelle DimzaKansas City$12K
- Raja ZaghlolKansas City$5K
- Mohamed El KhashabKansas City$4K
- Jane TitteringtonKansas City$4K
- Daniel HarrisonKansas City$1K
- Deepthi VodnalaOverland Park$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.